trial · primary record
Inavolisib
Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 420 |
| Primary completion | 2029-03-30 |
| Primary endpoint | Blinded Independent Central Review (BICR)-Assessed Progression Free Survival (PFS) |
| Registry ID | NCT05646862 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:51.899Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05646862
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.